Filing Details
- Accession Number:
- 0001237899-19-000038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-13 18:03:12
- Reporting Period:
- 2019-12-11
- Accepted Time:
- 2019-12-13 18:03:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1697422 | R. Christopher Fenimore | 777 Old Saw Mill River Road Tarrytown NY 10591 | Vp Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-11 | 1,020 | $0.00 | 9,697 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2019-12-11 | 2,500 | $0.00 | 12,197 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2019-12-12 | 3,100 | $52.03 | 15,297 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-12 | 1,418 | $377.16 | 13,879 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2019-12-13 | 191 | $374.82 | 13,688 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-13 | 624 | $375.58 | 13,064 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-13 | 470 | $376.27 | 12,594 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-13 | 346 | $377.38 | 12,248 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-13 | 51 | $378.27 | 12,197 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-12-12 | 3,100 | $0.00 | 3,100 | $52.03 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2019-12-11 | 6,120 | $0.00 | 6,120 | $372.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,226 | 2021-12-16 | No | 4 | M | Direct | |
| 6,120 | 2029-12-11 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,401 | Indirect | By 401(k) Plan |
| Common Stock | 1,897 | Indirect | By Trust |
| Common Stock | 509 | Indirect | by 2017 GRAT |
| Common Stock | 2,284 | Indirect | by 2018 GRAT |
Footnotes
- Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 11, 2021 and 50% on December 11, 2023.
- Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 11, 2023.
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 191 shares of Company stock on December 13, 2019 at prices ranging from $374.65 to $374.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 13, 2019 at each separate price.
- Represents volume-weighted average price of sales of 624 shares of Company stock on December 13, 2019 at prices ranging from $375.05 to $375.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 13, 2019 at each separate price.
- Represents volume-weighted average price of sales of 470 shares of Company stock on December 13, 2019 at prices ranging from $376.02 to $376.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 13, 2019 at each separate price.
- Represents volume-weighted average price of sales of 346 shares of Company stock on December 13, 2019 at prices ranging from $377.09 to $377.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 13, 2019 at each separate price.
- These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
